The Moderna share price: have I missed the boat?

After rallying over 300% in the past year, Jonathan Smith offers his opinion on whether the Moderna share price still offers value.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The impact of the Covid-19 pandemic has been felt in many ways over the past year. In the stock market, it was the trigger for the market crash of March 2020. However, some stocks have seen a rising share price associated with the virus. One example is the Moderna (NASDAQ: MRNA) share price, that’s up over 300% over the past year. This is largely thanks to the vaccine development. After such a stellar run, the question is whether I’ve missed the boat to buy now.

The story behind the rally

Moderna was a well known US-based company even before the pandemic hit. It went public in 2018, and became the largest biotech IPO in history with a valuation of $7.5bn. 

Despite the lofty valuation, the Moderna share price traded quite flat after going public. In my experience, this is the case with drug discovery and development companies. When FDA approval comes through, or a drug reaches commercial viability, the share price often rockets higher. Before this point, high research costs can burden the company.

For Moderna, it jumped on the opportunity to help with finding a vaccine for Covid-19. This progress started in March last year, coinciding with the start of the rally in the share price. 

The price spiked further in November, when the vaccine (mRNA-1273) showed a 94% efficacy rate. The subsequent green light given for distribution, not only in the US but in other countries, continued to support the rally into 2021.

Over the past month, the share price has trod water around the $130 mark. This is down from the highs above $170 seen a few months back, but at the same time is a substantial increase from where it traded a year ago.

My outlook for the Moderna share price

In my opinion, Moderna are doing all the right things at the moment. The vaccine has even reached us in the UK, with it being offered out this week. The company is planning on supplying up to 1bn doses globally this year.

However, what about the finances? For 2020 revenue was $803m compared to $60m in 2019. However, due to high research and development costs, Moderna recorded a loss of $747m.

In my opinion, a lot of investors are buying the stock for speculative purposes. Fundamentally, I don’t see the business as being worth the current valuation of over $50bn. I understand high losses in 2020 may be reduced in 2021 now that it has the vaccine, but even then, I don’t see the numbers stacking up.

As an investor, I want to be able to see a future where stable and strong profits are generated. This is one of the key boxes that Moderna doesn’t tick for me, so I won’t be buying.

This isn’t to say that the Moderna share price can’t rally higher this year, indeed I think buyers will drive the price higher. But as a long-term investor, I don’t see this being supported in years to come.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

jonathansmith1 has no position in any of the shares mentioned. The Motley Fool UK has recommended Moderna Inc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Here’s why I’ve changed my mind on this plummeting FTSE 100 share!

I was confident that this FTSE 100 share would bounce back after its recent troubles. Now I'm not so sure,…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

The more Apple stock falls, the more tempting it looks!

After a 16% drop this year, Christopher Ruane has been eyeing adding some Apple stock to his portfolio. But has…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Is the Lloyds share price taking a breather before its next move up?

After an outstanding few years of performance, the Lloyds share price seems to have run out of steam in recent…

Read more »

Investing Articles

Down 18%, this FTSE 100 dividend stock just hit a 16-year low!

This blue-chip dividend stock is trading at its lowest level since 2009. Should I add it to my Stocks and…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

A profit warning sends the WPP share price 16% lower!

The WPP share price fell heavily today as investors digested the company’s latest trading update and profit warning.

Read more »

ISA Individual Savings Account
Investing Articles

3 things I look for when buying stocks for my Stocks and Shares ISA

Edward Sheldon is aiming to fill his Stocks and Shares ISA with picks that are capable of providing him with…

Read more »

Business woman creating images with artificial intelligence inside office
Investing Articles

‘Britain’s Warren Buffett’ is betting on these AI stocks… but for how long?

Meta and Microsoft make up 17% of the Fundsmith Global Equity portfolio. But could higher capital intensity cause the 'UK’s…

Read more »

Exterior of BT head office - One Braham, London
Investing Articles

Near a 5-year high, is there still value in the BT share price?

With the BT share price near a five-year high, Mark Hartley analyses if there’s still value left for investors chasing…

Read more »